Rebecca has spent the last 25 years working with fast growth, innovative based companies in the MedTech, life science, CleanTech and FinTech sectors providing advice on stakeholder communications, issues and crisis management, investor and corporate relations, ESG, and business strategy to both private and public companies, research institutes, governments, and asset managers.

‍

She is a specialist in complex stakeholder engagement and management leading major M&A transactions and business transformation projects and has strong capital market experience working on more than 100 IPOs and RTOs and hundreds of secondary capital raisings. She has an investor network spanning communities in Australia, New Zealand, Asia, UK and US.

‍

Rebecca is Non-Executive Chair of Alcidion Limited, an ASX-listed international digital health business and Non-Executive Director of UK-based health and wellness company Ateria Health.

Bachelor of Journalism (Deakin University)

Post Graduate Certificate Applied Finance & Investment (FINSIA)

GAICD (Australian Institute of Company Directors)